Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA
Tóm tắt
Từ khóa
Tài liệu tham khảo
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020).
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).
Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2—preliminary report. N. Engl. J. Med. 383, 1920–1931 (2020).
Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020).
Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 396, 467–478 (2020).
Pfizer. Pfizer and BioNTech conclude phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine (2020).
US National Institute of Allergy and Infectious Diseases. Promising interim results from clinical trial of NIH-Moderna COVID-19 vaccine https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine (2020).
Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet https://doi.org/10.1016/S0140-6736(20)32661-1 (2020).
US Food and Drug Administration. FDA takes key action in fight against COVID-19 By issuing emergency use authorization for first COVID-19 vaccine https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 (2020).
US Food and Drug Administration. FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid (2020).
UK Medicines and Healthcare products Regulatory Agency. UK medicines regulator gives approval for first UK COVID-19 vaccine https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine (2020).
UK Department of Health and Social Care. Oxford University/AstraZeneca vaccine authorised by UK medicines regulator https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator (2020).
European Medicines Agency. EMA recommends first COVID-19 vaccine for authorisation in the EU https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu (2020).
Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S. & Tang, J. W. T. Herd immunity—estimating the level required to halt the COVID-19 epidemics in affected countries. J. Infect. 80, e32–e33 (2020).
Sanche, S. et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1470–1477 (2020).
de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P. & Larson, H. J. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 396, 898–908 (2020).
Bellaby, P. Communication and miscommunication of risk: understanding UK parents’ attitudes to combined MMR vaccination. BMJ 327, 725–728 (2003).
Lo, N. C. & Hotez, P. J. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr. 171, 887–892 (2017).
Geldsetzer, P. Knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom: a cross-sectional online survey. Ann. Intern. Med. 173, 157–160 (2020).
Pennycook, G., McPhetres, J., Zhang, Y., Lu, J. G. & Rand, D. G. Fighting COVID-19 misinformation on social media: experimental evidence for a scalable accuracy-nudge intervention. Psychol. Sci. 31, 770–780 (2020).
Salathé, M. & Bonhoeffer, S. The effect of opinion clustering on disease outbreaks. J. R. Soc. Interface 5, 1505–1508 (2008).
McAndrew, S. & Allington, D. Mode and frequency of COVID-19 information updates, political values, and future covid-19 vaccine attitudes. Preprint https://doi.org/10.31234/osf.io/j7srx (2020).
Tyson, A., Johnson, C. & Funk, C. U.S. public now divided over whether to get COVID-19 vaccine. Pew Research Center https://www.pewresearch.org/science/2020/09/17/u-s-public-now-divided-over-whether-to-get-covid-19-vaccine/ (2020).
Peretti-Watel, P. et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect. Dis. 20, 769–770 (2020).
Galvão, J. COVID-19: the deadly threat of misinformation. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(20)30721-0 (2020).
Altmann, D. M., Douek, D. C. & Boyton, R. J. What policy makers need to know about COVID-19 protective immunity. Lancet 395, 1527–1529 (2020).
Islam, M. S. et al. COVID-19–related infodemic and its impact on public health: a global social media analysis. Am. J. Trop. Med. Hyg. 103, 1621–1629 (2020).
Kim, H. K., Ahn, J., Atkinson, L. & Kahlor, L. A. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: a multicountry comparative study. Sci Commun 42, https://doi.org/10.1177/1075547020959670 (2020).
Kreps, S. E. & Kriner, D. Medical misinformation in the COVID-19 pandemic. SSRN https://doi.org/10.2139/ssrn.3624510 (2020).
Murphy, J., Vallières, F. & Bentall, R.P. et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 12, 29 (2021).
Roozenbeek, J. et al. Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 7, 201199 (2020).
Romer, D. & Jamieson, K. H. Conspiracy theories as barriers to controlling the spread of COVID-19 in the U.S. Soc. Sci. Med. 263, 113356 (2020).
Ernala, S. K., Burke, M., Leavitt, A. & Ellison, N. B. How well do people report time spent on Facebook? In Proc. 2020 CHI Conference on Human Factors in Computing Systems (ACM, 2020); https://doi.org/10.1145/3313831.3376435
National Health Service England. Protect your loved ones https://www.nhs.uk/apps-library/nhs-covid-19/ (2020).
National Health Service England. We must keep on protecting each other https://coronavirusresources.phe.gov.uk/Hands-Face-Space-/resources/co-branded-posters/ (2020).
US Centers for Disease Control and Prevention. Do it for yourself and your friends. https://www.cdc.gov/coronavirus/2019-ncov/downloads/Young-Mitigation-recommendations-resources-toolkit-COL.pdf (2020).
US Centers for Disease Control and Prevention. Wear a mask to protect you and your friends. https://www.cdc.gov/coronavirus/2019-ncov/downloads/Young-Mitigation-recommendations-resources-toolkit.pdf (2020).
Vraga, E. K. & Bode, L. Defining misinformation and understanding its bounded nature: Using expertise and evidence for describing misinformation. Political Commun. 37, 136–144 (2020).
Graham, M. & Coppock, A. Asking about attitude change. Public Opinion Quarterly (in the press).
Zhu, B. et al. Brief exposure to misinformation can lead to long-term false memories. Appl. Cogn. Psychol. 26, 301–307 (2012).
Paul, E., Steptoe, A. & Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Reg. Health Eur. https://doi.org/10.1016/j.lanepe.2020.100012 (2020).
Malik, A. A., McFadden, S. M., Elharake, J. & Omer, S. B. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 26, 100495 (2020).
de Figueiredo, A. Sub-national forecasts of COVID-19 vaccine acceptance across the UK: a large-scale cross-sectional spatial modelling study. Preprint at medRxiv https://doi.org/10.1101/2020.12.17.20248382 (2020).
Callaghan, T. et al. Correlates and disparities of COVID-19 vaccine hesitancy. SSRN https://doi.org/10.2139/ssrn.3667971 (2020).
Motta, M., Callaghan, T. & Sylvester, S. Knowing less but presuming more: Dunning–Kruger effects and the endorsement of anti-vaccine policy attitudes. Soc. Sci. Med. 211, 274–281 (2018).
Bakshy, E., Messing, S. & Adamic, L. A. Exposure to ideologically diverse news and opinion on Facebook. Science 348, 1130–1132 (2015).
Del Vicario, M. et al. The spreading of misinformation online. Proc. Natl Acad. Sci. USA 113, 554–559 (2016).
Del Vicario, M., Quattrociocchi, F., Scala, S. & Zollo, F. Polarization and fake news: early warning of potential misinformation targets. ACM Trans. Web 13, 10 (2019).
Schmidt, A. L., Zollo, F., Scala, A., Betsch, C. & Quattrociocchi, W. Polarization of the vaccination debate on Facebook. Vaccine 36, 3606–3612 (2018).
Cossard, A. et al. Falling into the echo chamber: the Italian vaccination debate on Twitter. In Proc. 14th International AAAI Conference on Web and Social Media 130–140 (AAAI, 2020).
Vosoughi, S., Roy, D. & Aral, S. The spread of true and false news online. Science 359, 1146–1151 (2018).
Pluviano, S., Watt, C. & della Sala, S. Misinformation lingers in memory: failure of three pro-vaccination strategies. PLOS ONE 12, e0181640 (2017).
US Census Bureau. Census regions and divisions of the United States. https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf (2010).
An Overview of the 3 NUTS and 2 LAU Layers in the UK (UK Office for National Statistics, accessed September 2020); https://www.ons.gov.uk/methodology/geography/ukgeographies/eurostat
Rubin, D. B. Estimating causal effects of treatments in randomized and nonrandomized studies. J. Educ. Psychol. 66, 688–701 (1974).
Bürkner, P. & Charpentier, E. Modelling monotonic effects of ordinal predictors in Bayesian regression models. Br. J. Math. Stat. Psychol. 73, 42–451 (2020).
McElreath, R. Statistical Rethinking: A Bayesian Course with Examples in R and STAN (CRC Press, 2020).
Wang, C., Dominici, F., Parmigiani, G. & Zigler, C. M. Accounting for uncertainty in confounder and effect modifier selection when estimating average causal effects in generalized linear models. Biometrics 71, 654–6565 (2015).
Boes, S. Nonparametric analysis of treatment effects in ordered response models. Empir. Econ. 44, 81–109 (2013).
Volfovsky, A., Airoldi, E. M. & Rubin, D. B. Causal inference for ordinal outcomes. Preprint at arXiv https://arxiv.org/abs/1501.01234 (2015).
Gelman, A. & Rubin, D. B. Inference from iterative simulation using multiple sequences. Stat. Sci. 7, 457–472 (1992).